As always, things are changing rapidly in the world of CBD. It’s looking increasingly likely that we may see a comprehensive cannabis reform package pass Congress within the next two years, and the US hemp industry is booming like never before.
At the same time, however, the detractors of hemp-based CBD are becoming more apparent. This plant’s unsettling power as a bioaccumulator is coming to light, and the details are shocking. Cannabis sativa’s thirsty roots suck up practically everything they come into contact with, and once it’s inside your cannabis, it’s essentially impossible to get out.
As the world’s premier non-hemp alternative to CBD-rich hemp oil, Citrus CBD is finally getting some well-deserved attention, and our small Portland company is rapidly getting a name for itself around the world. When I first met the Citrus CBD team back in July, I was told about some opportunities in the works that would exponentially expand the reach of this brand’s unique CBD products. I never would’ve expected, however, that it would all happen so quickly.
Our budding partnership with New Seasons
New Seasons is a regional chain of natural food stores with locations in Oregon and California. This prestigious natural health organization now carries our flagship transdermal CBD patches in each of its more than 20 locations, and initial reports from customers indicate that our patches are the most popular CBD products on New Seasons shelves.
As part of our ongoing customer education initiatives, we have strongly encouraged New Seasons staff to direct their customers to our webpage. If you’ve come across a Citrus CBD product at a New Seasons store and you’d like to learn more, you’ve come to the right place.
We are proud of our partnership with New Seasons, and we want to support our boots on the ground as much as possible. Stay tuned to our blog and follow Citrus CBD on social media to find out when our team will be in your area to perform a demo at your local New Seasons store. While you’re there, check out some of the other amazing natural products that are offered at every New Seasons location.
International opportunities on the horizon
Around the world, most people would look at our cannabis laws and count us as lucky. While there is still a long way to go until CBD and the other beneficial constituents of the hemp plant get the recognition they truly deserve, possession of anything even remotely related to marijuana often earns you life imprisonment or even death in many parts of the globe.
Nowhere is this pain more keenly felt than in East Asian countries. People in Japan, Hong Kong, Singapore, and South Korea love American culture just as much as we do, and everything that Americans have, Asians generally want.
That’s why the status of cannabis law in most Asian countries is so tragic. Even if it doesn’t contain any THC, if that hemp flower in your pocket smells like weed, you might find yourself in the darkest sanctum of a totalitarian gulag in ten seconds flat.
People in East Asian countries are desperate for CBD products that they can actually sell and use within their restrictive legal frameworks. We’re excited to say that Citrus CBD has recently been approached by Asian partners interested in international distribution. Our little brand is growing fast, and it’s all thanks to the incredible power of citrus-derived CBD.
Expect to see Citrus CBD a lot more places
Asian partnerships aren’t the only opportunities on the horizon for Citrus CBD. A variety of major retailers in the United States have also expressed interest in offering our products, and negotiations are in the works. Even though cannabis law is far less restrictive in the United States than it is abroad, many companies want to move away from the hemp industry since it’s seen as volatile.
That’s how we got our start at New Seasons. Like many other regional chains, New Seasons wanted to insulate itself against the uncertainties of the domestic hemp industry, which is certainly wise. You never know what might happen with hemp-derived CBD, and while great strides have been taken toward domestic, organic hemp agriculture, some companies still use low-grade hemp from China to make their CBD products. Consumers have learned to distrust the CBD industry for good reason, and here at Citrus CBD, we are the antidote to your disillusionment.
New products coming soon!
We’ve been teasing a new line of products for a while now, and we’re pleased to announce that our Entourage Patch, oral capsules, and a few other products are almost ready for release. Soon, there will be even more that you can do with molecularly reconstructed cannabinoids, and here at Citrus CBD, we’ll never stop innovating the citrus-derived cannabidiol solutions the world so desperately needs.
CBD is becoming more popular with each passing day. While a persistent lack of regulatory oversight is preventing CBD from becoming a first-line treatment, even mainstream medical practitioners are having to admit that this non-psychoactive may be more effective than conventional medications for conditions like depression, anxiety, migraines, and inflammatory pain.
The CBD industry is currently caught in a convoluted web of legal complexities. While cannabis-derived CBD is certainly more legal now than it ever has been before, cannabis and hemp investors are right to be cautious. Hemp-derived CBD may remain legal for general market sale for years to come, but it’s just as likely that every hemp-based CBD product in the country will be pulled from shelves tomorrow.
Recently, pioneering CBD scientists have succeeded in deriving the cannabidiol molecule from natural citrus terpenes. Since this type of CBD doesn’t come from cannabis, it isn’t affected by the legal uncertainty that threatens the hemp CBD industry. Learn all about the citrus-derived CBD in Citrus CBDTMand why this new form of cannabidiol offers more stability in both domestic and worldwide markets.
What Is Citrus-Derived CBD?
If you think it’s impossible to derive CBD from anything other than cannabis, that’s only natural. After all, cannabis-derived CBD has been the only option on the market until now. While companies have claimed to derive CBD from sources other than cannabis before, these claims have been heavily scrutinized, and all previous “non-hemp CBD” products that arrived with so much fanfare have gradually skulked their way into nonexistence.
Citrus-derived CBD, however, is the real deal. And no, nobody’s claiming that you can extract ready-made CBD molecules from citrus peels. On the contrary, the process behind the CBD in Citrus CBDTM involves a technique called Cyclic Terpene Assembly (CTA), which reconstructs terpenes naturally found in citrus into CBD molecules.
The CBD in Citrus CBDTM is bio-identical with cannabis-derived CBD, which means that it has the exact same chemical structure. Since it is molecularly identical with cannabis-derived CBD, citrus-derived CBD exerts the same benefits as CBD molecules found in any other sources.
There is, however, one important difference between the CBD in Citrus CBDTM products and the cannabidiol found in hemp: Citrus-derived CBD has nothing whatsoever to do with cannabis. CBD derived from citrus has never come in contact with a single THC molecule, and it is not legally connected to hemp, cannabis, or marijuana.
As I continue, I’ll explain exactly what this critical difference means for Citrus CBDTM customers and the future of the CBD industry. Briefly, however, I’ll point out the most important factor: All existing legislation pertaining to CBD, whether in the United States or abroad, refers specifically to a compound found in the Cannabis sativa plant. Citrus-derived CBD offers the same benefits as cannabis-derived CBD, but it’s in a uniquely liberated legal position.
The History of U.S. Cannabis Law
To fully understand the importance of the advent of citrus-derived CBD, it’s important to take a look at the history of hemp and cannabis law as a whole. Throughout the vast majority of the history of cannabis use within human societies, people have viewed this plant quite favorably. Cannabis is an high-yielding food and fiber crop, and its medicinal quantities have been documented for at least 3,000 years.
During the last century, however, a sweeping cannabis prohibition initiative has taken place worldwide, and in the eyes of the public, Cannabis sativa has transformed from a useful crop and beneficial medicine into a public menace. Marijuana certainly isn’t as harmless as cannabis sector lobbyists would like you to believe, but as toxic drugs like Xanax and Percocet have flowed freely into the arteries and veins of the American people, marijuana prohibition has landed countless otherwise law-abiding citizens in prison and greatly diminished the public reputation of Cannabis sativa in general.
The most significant casualty of cannabis prohibition has been the systemic overlooking of this plant’s potential medical benefits. Since the 1940s, medical researchers have been aware that cannabis contains dozens of different plant-based phytocannabinoids, and one of these cannabinoids, CBD, has gotten the lion’s share of attention despite the anti-cannabis attitude caused by prohibition.
In recent years, however, significant legal changes have allowed the CBD industry to blossom outside the confines of state-sanctioned medical or recreational marijuana programs. CBD is now widely-available as a general market, over-the-counter product, but how did these changes come into being, and what bearing do they have on the legality and future of citrus-derived CBD?
Recent Changes to CBD Law
Throughout the 1990s and 2000s, the benefits of CBD became more widely known. However, use of this beneficial cannabinoid was restricted to drug-using populations; CBD-rich strains of cannabis were limited or nonexistent, and the only way to use CBD was to ingest it alongside relatively high concentrations of psychoactive THC.
In 2014, however, everything changed as the federal government quietly changed its definition of marijuana. Practically overnight, dozens of CBD companies appeared on the internet, and it became possible to purchase cannabidiol products anywhere in the country and have them shipped directly to your door. The changes to American CBD law, however, had only just begun.
The 2014 Farm Bill
During President Obama’s second term, the U.S. Congress passed the Agricultural Act of 2014 (2014 Farm Bill). Like farm bills before it, this piece of legislation set aside funding for agricultural activities and made various amendments to existing farming law. The section of the 2014 Farm Bill that drew the attention of the cannabis industry, however, was the passage relating to industrial hemp.
The purpose of this section of the Farm Bill was to resolve legal complexities surrounding industrial hemp research. Prior to 2014, universities and other research organizations that wanted to learn more about hemp had to jump through various bureaucratic hoops, which impeded the acquisition of new knowledge regarding hemp and its practical uses.
In effect, however, Section 7606 of the Agricultural Act of 2014 reclassified any cannabis product containing less than 0.3% THC from “marijuana” to “industrial hemp.” Previously, all Cannabis sativa had been legally classified as identical with marijuana, but with the passage of the Farm Bill, CBD products containing less than the legally-defined maximum THC concentration were suddenly eligible for general market sale.
Almost immediately, the federal government realized it had made a mistake. While the letter of the law made it clear that the 2014 Farm Bill wasn’t intended to establish government-sanctioned domestic CBD trade, the bill’s new definition of “industrial hemp” served as an iron-clad loophole that manufacturers could use to start selling CBD products directly to American consumers.
The 2018 Farm Bill
The years between 2014 and 2018 weren’t without their scares for the safety of the fledgling CBD industry. More than once, U.S. Drug Enforcement Agency (DEA) actions and veiled threats to CBD manufacturers led to fears that a widespread crackdown on general market CBD was imminent.
To clear up any potential ambiguity, the 2018 Farm Bill stripped CBD from the DEA’s list of scheduled drugs altogether. Cannabis-derived CBD is no longer lumped in with marijuana as a Schedule I drug, and as far as the federal government is concerned, you can no longer face prosecution for use or possession of CBD.
Many within the CBD industry greeted this news with elation. It’s true; removing CBD from the DEA’s definition of marijuana is a huge step in the right direction. Industry veterans, however, immediately hit the books to determine what this move meant for the evolution of the CBD industry in coming years.
The Future of CBD Law in the USA
Since the beginning of its surge in popularity, CBD has been troublesome to the federal government for a number of reasons:
As a simple plant extract, it’s hard to reap the enormous profits from CBD that pharmaceutical companies are used to deriving from prescription drugs. Therefore, there’s not much incentive to research this substance.
CBD is related to marijuana, which has genuine health risks and has historically been a principal target of the War on Drugs.
CBD could replace the market for a variety of drugs designed for conditions for which CBD may be a safer and more effective treatment.
In recent years, however, CBD has become an even greater thorn in the government’s side, but for a different reason: It isn’t taxed or regulated. The FDA is used to serving as the gatekeeper of drug access in American society; if the FDA hasn’t approved a substance, this agency can’t bear the thought of that substance ending up in the hands of U.S. consumers.
The FDA serves a critical role in protecting public health, but this agency has also increasingly become the stalwart defender of the interests of the pharmaceutical industry. Big Pharma makes up a significant portion of the U.S. economy, and any disruptions to the flow of drugs from factories to pharmacies to consumers could reduce America’s economic strength and, as an extension, the country’s national security.
What does all this mean? In a nutshell, it means that the federal government isn’t done with CBD. While recent legislative changes may seem like nods to a CBD industry that’s become too large to control, it’s far too soon to say whether the federal government’s stance toward cannabidiol will continue to be so permissive.
In fact, recent remarks from the FDA unequivocally indicate that this agency is likely to crack down on cannabis-derived CBD edibles sooner or later. During a recent public hearing held to discuss the future of the CBD industry with stakeholders, FDA representatives clearly stated that drugs shouldn’t be in the food supply, which indicates two things:
The FDA is beginning to look at CBD as a pharmaceutical drug rather than a supplement;
The FDA plans to take action to control the presence of CBD in the food supply.
As with all other bureaucracies, the FDA takes forever to get anything done. As a result, many CBD manufacturers still have the attitude of, “make hay while the sun shines,” but it’s pretty clear that the sun won’t shine so brightly on the cannabis-derived CBD industry forever.
In the end, hemp-derived CBD’s relationship with marijuana is too problematic to ignore, and as CBD becomes more and more popular, the FDA will be under increasing pressure to simply cut the Gordian Knot and eliminate cannabis-based CBD from the general market altogether. As the cannabis-based CBD industry faces ever-greater volatility, entrepreneurs and consumers are turning toward cannabis alternatives that offer all the benefits of hemp-derived CBD.
CBD Legislation is Globally Unstable
It’s not just in the United States that the CBD industry is in turmoil. All around the world, governments are struggling to determine how to deal with the CBD phenomenon, and many countries are making the unfortunate mistake of coming down on the side of restricting access to this natural, beneficial compound entirely.
In Canada, for instance, CBD law is a mess. As one of the first counties to fully legalize marijuana for recreational use, you’d think that Canada would have some of the most progressive CBD laws. While it’s true that your chances of getting arrested for CBD in Canada are about as likely as finding a naturally-occurring palm tree in Quebec, Canadian legislators still can’t decide if CBD products are legal if they aren’t sold through state-sanctioned recreational marijuana stores.
In the European Union (EU), the only country to boast an unrestricted CBD market is Bulgaria. In other European countries, CBD law is in a state of flux, and citizens of these countries aren’t sure whether or not it’s okay to use this cannabis-based substance.
Nations like Japan and China, which have some of the strictest penalties for drug possession, offer no room for people to try the benefits of CBD, and most other countries around the world impose similarly restrictive cannabis-derived CBD policies.
Citrus-Derived CBD Sidesteps Legal Concerns
At present, the growth potential of the CBD industry suffers from a fatal flaw: Cannabis-derived CBD is inextricably tied together with marijuana, and meaningful reform to the status of CBD won’t be achieved until Western society changes its stance toward cannabis in general. Just as important to note, however, is the equally fatal flaw inherent to all modern CBD legislation: Lawmakers around the world seem incapable of defining CBD as anything other than a cannabis derivative, and any CBD not sourced from cannabis is not regulated under existing CBD laws.
Just to break it all down: All existing cannabis legislation pertains to CBD-rich hemp (cannabis) oil, not to the CBD molecule itself.
I won’t lie. It’s entirely possible that, somewhere along the road, current efforts to regulate CBD will need to “do a 180” and re-address CBD that isn’t derived from cannabis. At the current stage of the game, however, going back and altering existing laws to deal with CBD itself instead of CBD-rich hemp oil would simply introduce more volatility into the CBD market at the same time that various governmental organizations around the world are trying to stabilize and profit off this mounting trend. Until major governments settle on how to regulate cannabis-derived CBD, which will take years, the CBD molecule itself will remain free from regulatory scrutiny.
Here’s the bottom line:
Citrus-derived CBD is legally unrelated to cannabis, marijuana, or hemp;
Current CBD legislation regulates CBD-rich hemp oil, not the CBD molecule itself;
Therefore, citrus-derived CBD is not regulated under any existing laws, which makes it available in regions where sourcing cannabis CBD is difficult or impossible.
The advent of citrus-derived CBD opens up incredible opportunities within the global CBD market. Many countries have far stricter marijuana laws than those enforced in the United States, which has made CBD access all-but impossible to the majority of the global population. Due to the unique legal status of citrus-derived CBD, however, it is possible to market this product anywhere in the world without facing the legal hurdles surrounding cannabis-based substances.
CBD-Rich Hemp Oil and the CBD Molecule: Is There a Difference?
Is citrus-derived CBD different from cannabis-derived CBD in a chemical sense? No. Are citrus-derived and cannabis-derived CBD different legally? Yes.
In my time observing the evolution of the CBD industry, I’ve been floored more than once by unexpected innovations that have gone on to change the future of CBD forever. The CBD industry is in a constant state of flux, and in my opinion, things won’t begin to settle down for at least another decade. In the meantime, however, citrus-derived CBD is poised to provide safe, reliable access to CBD to people who would never have had a chance to try this cannabinoid otherwise.
I’ll say it again: Independent lab reports confirm that the CBD in Citrus CBDTM products is molecularly identical to cannabis-derived CBD. It has all the same atoms as CBD sourced from cannabis, which means that it affects the body the same way. In fact, preliminary results show that the citrus-derived CBD in Citrus CBDTM products may actually be more inherently bioavailable than CBD found in cannabis.
Even though it seems too good to be true, Citrus CBDTM is the real deal. After years of rumors about non-cannabis CBD that ended up fizzling out, the scientists at Citrus CBDTM have succeeded in delivering the world’s first viable alternative to CBD derived from hemp. Citrus CBDTM is real CBD, it works just as well, and it’s far more legal than any compound with ties to cannabis or marijuana could ever hope to be.
Enjoy CBD Worry-Free with Citrus CBD
Science has unequivocally determined that there are a lot of potential benefits of CBD that should be examined further. However, there are just as many reasons for consumers to be skeptical about this modern-day miracle cure. Despite the best assurances of any company offering full-spectrum CBD, which contains up to 0.3% THC, there’s no guarantee you won’t fail a drug test when you ingest THC in any quantity, and the legal status of hemp-derived CBD is still up in the air in every state in the Union and around the world.
Many consumers understandably don’t want to have anything to do with any product that’s connected with marijuana, and this position isn’t just based on backward views and silly phobias. Marijuana is a seriously dangerous drug; it slows brain development in teens, it contributes to psychosis, and it’s highly addictive. There’s a good reason marijuana hasn’t yet been fully accepted into the fabric of American society, but CBD’s connection with this illegal drug is preventing too many people from experiencing this non-psychoactive cannabinoid’s healing benefits.
It’s the firmly-held mission of the Citrus CBDTM to provide, safe, reliable access to cannabidiol products that have no relationship with marijuana whatsoever. In the past, choosing to use CBD required running a precariously-balanced cost-benefit analysis; is the risk of ingesting THC, pesticides, or solvents worth the benefits of using CBD? Will I be arrested for using this apparently harmless, non-psychoactive compound?
With Citrus CBDTM, the impressive benefits of CBD have been released from their prison of legal complexities and sourcing concerns. It’s now possible to enjoy the benefits of CBD without having to worry about getting high, failing a drug test, or using illegal drugs, and the Cyclic Terpene Assembly process eliminates any possibility of the presence of contaminants. With super-bioavailable transdermal patches and extended-release capsules available, you can now enjoy the benefits of CBD worry-free with citrus-derived Citrus CBDTM.
If you’re wondering how it’s possible to get CBD from citrus, you aren’t alone. When I first heard of citrus-derived CBD and spoke with the Citrus CBDTM team, I was just as skeptical as you are. After getting to know George and learning more about citrus-derived CBD, however, I became convinced; Citrus CBDTM is the real deal, and it has the potential to solve some of the biggest problems facing the CBD industry.
Is Citrus CBD Real CBD?
It turns out that extracting CBD from cannabis isn’t the only way to source this increasingly-popular cannabinoid. After years of research and extensive investment, CBD researchers have successfully developed a sustainable, cost-effective method for reassembling molecularly identical CBD from natural compounds found in citrus peels. This proprietary process, called Cyclic Terpene Assembly (CTA), sidesteps many of the legal complexities hindering the growth of the CBD industry and provides CBD users with non-hemp, non-cannabis, THC-free cannabidiol.
It’s understandable if that all sounds a little complicated. Let me break it down:
Terpenes are present in lots of different plants. Many citrus fruits contain terpenes.
These terpenes are chemically similar to cannabinoids. Cannabis contains tons of terpenes, and they help make some kinds of cannabis-derived CBD more effective.
It’s now possible to transform terpenes present in citrus plants into pure cannabidiol molecules. Using a proprietary process, the scientists behind Citrus CBDTM have succeeded in creating a sustainable and cost-effective method for turning terpenes in citrus peels into CBD.
These citrus-derived CBD molecules are molecularly identical to cannabis-derived CBD molecules, which means that they have the same effects.
Legality of Citrus CBDTM
Citrus-derived CBD is not a hemp, cannabis, or marijuana product. At present, the FDA has not decided on a regulatory structure for the CBD industry, and neither it nor any other agency worldwide has put restrictions on the CBD molecule itself. This molecule is not patented.
Whether in the USA or abroad, therefore, laws that pertain to cannabis, hemp, or marijuana do not apply to citrus-derived CBD. Also, like cannabis-derived CBD isolate, citrus-derived CBD does not contain any THC whatsoever, so it cannot be construed as a marijuana product. Since the citrus-derived CBD offered by Citrus CBDTM does not contain any THC, it is not possible to fail a drug test for THC after using a Citrus CBDTM product.
Citrus-derived CBD occupies a unique legal status within global cannabidiol law. Consumers can use Citrus CBDTM products with confidence knowing that do not contain any THC and are in no way related to illegal drugs.
Definition of Terms
While misleading marketing material for cannabis-derived CBD might have told you otherwise, cannabis, hemp, and marijuana are all the same plant. Some cannabis has simply been bred to be high in THC (marijuana), and some has been bred to be high in CBD (or not high in any cannabinoids at all).
2. Molecularly Identical/Bio-identical
These terms also mean the same thing. Under a microscope, citrus-derived CBD has the same molecular structure as CBD derived from cannabis.
Citrus CBD is bio-identical to CBD from cannabis
Is Citrus CBD Molecularly Identical to Hemp CBD?
Yes, the citrus-derived CBD in Citrus CBDTM is bio-identical to CBD in every way, shape, and form. Unlike full-spectrum CBD-rich hemp oil, the cannabidiol in Citrus CBDTM does not contain omega fatty acids, terpenes, or other trace cannabinoids. In this way, it most closely resembles isolate CBD derived from cannabis plants, but it is not cannabis-derived.
Good question. The simple answer is, “No,” but it’s important to examine the complexities of this question to answer it thoroughly.
Citrus CBDTM is made from the peels of citrus fruits, which means it’s derived from organic substances rather than synthetic chemicals. However, creating CBD from reconstructed terpenes does involve breaking down and reassembling molecular structures, so in one sense of the word, CTA “synthesizes” CBD from natural terpenes present in citrus peels.
Rest assured, however, that Citrus CBDTM is all-natural and 100%-organic. It’s also worth pointing out once more that Citrus CBDTM is molecularly identical to cannabis-derived CBD, which means that it’s the last thing from a synthetic analogue. Citrus CBD is a natural, pure, and scientific alternative to unreliable and legally-complicated hemp-derived CBD.
Citrus CBDTM and the Environment
Hemp is usually grown and bred as a monoculture. Therefore, this practice degrades the soil even if organic farmers avoid using chemical pesticides and fertilizer. While hemp has dozens of uses, many CBD-rich cannabis cultivators do not use all the usable part of their plants. Additionally, hemp regulation is still in flux in the United States, and some hemp farmers do not have access to crop insurance, which leads to economic uncertainty.
In general, the U.S.-based cannabis-derived CBD industry is currently operating on the principle of, “Make hay when the sun shines.” There are quite a few ethical, high-quality cannabis-derived CBD manufacturers out there, but for every good producer, there are 10 more opportunists riding the “Green Rush” without putting enough thought into the quality or safety of their products. In the absence of effective regulatory oversight, the majority of cannabis-derived CBD manufacturers cut corners and overrepresent the safety and purity of their products.
Citrus CBDTM, on the other hand, is molecularly restructured from citrus peels. It is 99.7-99.9% pure, and since Citrus CBDTM was never grown, extracted, or stored as a plant oil, it cannot physically host any pesticides, fertilizers, or residual solvents.
Every year, citrus producers in Central and South America throw away millions of tons of citrus peels. Citrus CBDTM puts these waste products to good use by turning natural citrus molecules into CBD. Hemp and cannabis, on the other hand, are “virgin” sources of CBD; they are grown expressly for the purpose of extracting CBD-rich hemp oil, and cannabis plants grown for CBD production may be discarded before their immense usefulness is fully exploited.
Can citrus-derived CBD deliver real relief?
Benefits of Citrus-Derived CBD
Citrus-derived CBD is identical to cannabis-derived CBD, so it provides the same benefits. Science has discovered that the CBD molecule appears to provide a variety of different beneficial effects. First, let’s cover a couple of the mechanisms of action that scientists think help explain CBD’s observed benefits:
1. 5-HT1A Activation
The 5-HT1A neuroreceptor (serotonin 1A receptor) is the most abundant serotonin receptor in the brain. While many educated consumers are aware that serotonin has a big impact on mood, this neurotransmitter is also responsible for a variety of other critical biological functions. CBD’s reported antipsychotic, antidepressant, and anxiolytic effects appear to be related to this cannabinoid’s agonistic, or activating, effects at the 5-HT1A receptors.
2. TRPV1 Activation
CBD is observed to bind to the TRPV1 receptors, which modulate the perception of pain, seizures, and perhaps most importantly, inflammation. Some scientists believe that inflammation contributes to the pathophysiology (process of development) for every type of disease, and interactions with the TRPV1 receptor would also explain the potent antiepileptic effects that CBD has been observed to exert.
synergistic phenomenon that occurs when multiple cannabinoids and other cannabis constituents, such as terpenes, are used simultaneously. Citrus-derived CBD is similar to CBD isolate; aside from an exceedingly small amount of CBDA, the CBD in Citrus CBDTM products does not contain any cannabinoids other than CBD.
Just as it’s possible to create CBD from citrus peels, however, it’s also possible to construct other cannabinoids from the natural compounds present in this unused waste product. The new Citrus CBDTM Entourage Transdermal Patch contains a 5/1 ratio of CBD to cannabigerol (CBG), which is another non-psychoactive cannabinoid that has unique benefits above and beyond CBD.
With this product, Citrus CBDTM is beginning to reconstruct the entourage effect using cannabinoids that aren’t derived from cannabis. In the future, it will be possible to choose whichever cannabinoids, terpenes, and other substances you want to include in your citrus-derived CBD topicals, capsules, and vape cartridges in whichever quantities you want. The more popular Citrus CBDTM becomes, the closer this dream comes to reality.
Can your body use all the CBD you ingest?
How Much Citrus CBDTM Can Your Body Absorb?
Citrus-derived, molecularly identical CBD may be more water-soluble than cannabis-derived CBD. Keep checking in as more research becomes available. What we know for sure, however, is that the body treats citrus-derived CBD similarly to cannabis-derived CBD. Therefore, it’s safe to say this much about absorption rates for this revolutionary non-hemp cannabinoid:
1. Oral Administration
Like cannabis-derived CBD, orally-administered CBD generally provides long-lasting, mild effects. However, some experts believe that more than 20% of the CBD you ingest internally is filtered out by the liver. While oral administration of CBD causes unique effects that many users find to be beneficial, this route of administration wastes a significant amount of the CBD you consume.
2. Pulmonary Administration
Pulmonary administration, or inhalation, of CBD provides better bioavailability than oral administration of this cannabinoid. However, the lungs still filter out a large percentage of the CBD you inhale. While pulmonary administration of CBD usually provides nearly immediate effects, the benefits of ingesting CBD via this method usually only last around half an hour.
3. Transdermal Administration
Research indicates that transdermal administration, also known as topical administration, is the most bioavailable method of CBD administration. Depending on the type of transdermal administration you choose, your body can use nearly 100% of CBD you apply to your skin. While the seven layers of your dermis are tricky to permeate, the skin’s filtration mechanisms hardly waste any of the CBD you apply.
Citrus-Derived CBD: The Bottom Line
It’s perfectly natural to be skeptical about citrus-derived CBD. In today’s CBD industry, cannabidiol users should be very cautious about the products they choose. With third-party lab testing confirming that the citrus-derived cannabidiol in Citrus CBDTM is molecularly identical to cannabis-based CBD, there’s no denying that citrus-derived CBD is the real deal.
The CBD industry is in an imperfect state right now. Consumers are concerned that their access to CBD could dry up tomorrow. They’re even more concerned about the contaminants that might be present in their favorite CBD products, and even though the Agriculture Improvement Act of 2018 (2018 Farm Bill) made CBD legally separate from marijuana, cannabis-derived CBD remains in a legal gray area everywhere in the United States.
Citrus-derived CBD is not cannabis, it is not hemp, and it is not marijuana. It is, on the other hand, the pure cannabidiol molecule liberated from its relationship to the unstable, unreliable, and legally-volatile Cannabis sativa plant. While the CBD industry will always owe its origins to the cannabis plant, the advent of citrus-derived CBD proves that the cannabis industry does not have a monopoly on cannabidiol or any other cannabinoid. CBD can be reconstructed from natural citrus peel constituents and made into incredibly pure, cost-effective, and easy-to-use cannabidiol products.
While there are still many problems in the CBD industry, the products offered by Citrus CBDTM go a long way toward solving them. It’s at the core of entrepreneurship to never be satisfied with achievements that have already been accomplished, and Citrus CBDTM has taken the next steps toward providing cannabidiol users with safe, consistent, access to bioavailable and sustainable CBD.
Tonight we had cannabis nurse Rebecca C. White join us to talk about health and cbd. We talk about drug interactions, how cannabis works with your body and some success stories as well. It was a great conversation with lots of great information. I know you'll get something from this episode!
This past summer The California Department of Public Health dealt a blow to hemp-based CBD companies statewide clarifying that in accordance with the FDA, CBD derived from industrial hemp is not approved in food and beverage. Here’s what you need to know.
As the popularity of CBD has grown, so has the trend to put CBD in a variety of food and beverage products. Retailers advertise CBD in Beer, Lattes, Chocolate and gummies. But not all CBD products have what it takes to be approved for consumption. On July 6th, The California Department of Public Health (CDPH) released a FAQ memo which declared that industrial hemp derived CBD and CBD Oil is currently not approved for food and beverage products until the Food and Drug Administration (FDA) declares otherwise.
The CDPH’s declaration isn’t a new ruling but merely a clarification on legalities that have become murky between Federal laws and State laws around industrial-hemp products and marijuana products. The memo came in response to a growing number of California companies reaching out with intent to use industrial hemp-derived CBD for food and beverage products. California’s stance on hemp-based CBD has created some controversy between the industrial-hemp industry and the marijuana Industry as the ruling only singles out the use of industrial hemp-derived CBD from food, placing many hemp farmers and companies in a confusing legal limbo.
CDPH declares that, excluding the usage of hemp-derived CBD from food conforms to the FDA ruling that all products produced from the genus cannabis are currently considered a Schedule I drug and therefore not approved or legal for food products. This places hemp and marijuana-derived CBD products as illegal at the federal level. But with California’s passage of Proposition 64, the state legalized adult-recreational marijuana and The CDPH Manufactured Cannabis Safety Branch regulates all marijuana production, therefore approves marijuana-derived CBD food products (edibles) to be sold at properly licensed dispensaries.
Industrial Hemp in California is regulated by the Federal law and the California Industrial Hemp Law. The cultivation of industrial hemp is only allowed in states where it is legal and only by registered seed cultivators and licensed research institutions under a pilot program for research and educational purposes. For commercial purposes, Hemp may only be grown as a fiber or oilseed crop. Currently under Federal and California State law, Hemp is not approved for food products.
So, by excluding hemp derived CBD from food and beverage, California is only following the current state and federal laws regarding Hemp. Marijuana is excluded from this ruling because California has legalized and regulates the manufacturing of cannabis products.
Another concern that comes up with Industrial hemp-derived CBD that creates an issue for its use in food and beverage is that there are no laws at the state or federal level that regulate CBD derived from industrial-hemp. There is growing concern that without proper regulations, more contaminants such as pesticides may be present and concentrated when CBD from industrial-hemp is extracted, posing unknown health risks to consumers.
In today’s market the demand for CBD has skyrocketed. With recent studies suggesting the health benefits, consumers are turning to CBD products as a natural source for their ailments, but can you trust your CBD product?
Everyone is talking about CBD these days, and putting it in almost everything. Recent studies that show the potential for CBD as a natural source for pain relief, sleep aid, tumor reduction and so much more, have people flocking to their local dispensary - or really anywhere they can get it.
This is where a red flag shows up. Marijuana is not legal in all 50 states, making it difficult for some to purchase CBD from a trusted dispensary-leading them to purchase products online. But with the booming CBD market, and with quality control standards varying from state to state, not all company’s can be trusted that their CBD products are free of contaminants.
Here are some growing concerns of contaminants in hemp- and cannabis-based CBD products that aren’t widely talked about, and some things you should consider before purchasing any CBD product:
Quality Concerns With Hemp or Cannabis-based CBD:
The major issue found with industrial hemp and cannabis crops is that they make amazing phytoremediation sources. Hemp and Cannabis suck up all sorts of toxins, chemicals, and metals from the soil - good or bad. But the bad is what we are worried about. When plants are doused with pesticides, or soils have heavy metals, these toxins are absorbed by cannabis and hemp and can be transferred to humans or pets through use.
It’s when we’re talking about CBD extractions where things get even more scary. There is growing concern that the extraction process of CBD when other toxins are present, can cause an alarming level of contaminants to be concentrated in the product - which are then consumed. This is in part why California recently banned industrial hemp-based CBD from all food and beverage products.
You must be thinking that just like California, other states have regulations in order that keep these products from entering our market today. Which leads me to the next major factor affecting consistent quality of hemp or cannabis-based CBD. At this time, third-party testing isn’t regulated the same from state to state; allowing some companies to find ways to sale CBD with questionable quality and save a pretty penny.
Sourcing Concerns of Hemp or Cannabis-based CBD:
The legalities of growing hemp and cannabis crops in the U.S. make it difficult for farmers to consistently source and meet the demands of CBD in our market today. This at times has caused some companies to outsource their CBD product; meaning they are sourcing from another country with different regulations on the cultivation of hemp and cannabis.
The concern is similar to what was mentioned previously - other countries have different regulations on pesticide or other chemical use to treat their crops. They also may have different regulations on where they can grow their crops and whether or not they test for heavy metals. If we don’t know where our CBD is sourced, how can we know exactly what we are taking?
When these products enter the U.S. market where we currently do not have standard regulations on third-party testing across all 50 states, there is no way to guaranteed that every CBD product in the market is free of contaminants such as pesticides and heavy metals.
What you can do to avoid the issues facing the CBD market:
If you are seeking CBD for medicinal purposes and depending on the severity it is advised to speak with a medical professional. If Marijuana is legal in your state for either medical or recreational use, ask your local dispensary where your product is coming from and if they have public third-party test results where you can research what exactly is in the product you are buying. Doing a little bit of research and knowing what questions to ask can help you find the best product and avoid contaminants.
If medical and recreational marijuana is not legal in your state or you simply want an alternative to hemp or cannabis based CBD, Citrus CBD may be a good option for you! Our daily CBD supplement is not associated with hemp or cannabis and is THC-free making is legal. We also have third-party test results of 99.7-99.9% purity, making our products free of contaminants.
With the growing CBD market, many are interested in trying CBD but may be hesitant due to their employer’s drug test policy. If you are concerned about drug screening here is what you should know about cannabis-based CBD products.
Nothing is more nerve wracking than a workplace drug test. Your results can determine your ability to be hired with a company or affect your current employment. Even in states where marijuana is legalized for recreational or medical use, employer’s reserve the right to a drug and alcohol-free workplace. You can be asked to perform a drug test during their hiring process, at random, or with cause such as a workplace accident. Legally, employers must provide a drug policy document for their employees to ensure that everyone is aware of what is allowed during employment.
So let’s tackle the million dollar question: If you take CBD, will it show up on your drug test? Most employers are only looking for THC with drug-screening. So technically no, CBD will not show up on your drug test. If you are taking a CBD product that is not derived from cannabis or hemp and CBD is the only cannabinoid in the product then you should be assured that you will pass, unless you are taking other drugs they might be looking for. If you are taking a CBD product that is derived from hemp or cannabis then the answer is still no, CBD will not show up on your drug test, but THC might.
If you’re concerned about drug testing, there are a few things you should be aware of before you try cannabis-derived CBD products:
You Could Test Positive for THC When Taking CBD Derived from Hemp or Cannabis:
January 2018, Jeff Anderson of Beaverton, OR lost his job as a bus driver for the Beaverton School District due to using a hemp-based CBD tincture. In an article posted by the local paper Willamette Week (WW) Anderson began using a CBD tincture to relieve pain caused by arthritis. He was aware of his employer’s drug policy and was explicit when buying the product that he could not test positive for THC. The dispensary where he purchased this tincture assured him that the trace amounts of THC would not be detected on a drug test. They were wrong, and in result Anderson lost his job due to high-levels of THC in his system.
So how did this happen? Well, the article goes on to explain that overtime, with daily uses of CBD products that have low-levels of THC present, THC can build up in fat cells causing it to show up on urine tests. Willamette Week even spoke to the company of the tincture Anderson was using and they state that they would never recommend using their CBD product to those subjected to drug-screening. It was a misconception on the budtenders part that these products with low-THC would not show up on a drug test, but there seems to be a common misunderstanding nationally. WW called multiple dispensaries in Oregon, Washington and Colorado that gave mixed responses on whether or not CBD products derived from hemp or marijuana with low levels of THC will show up on a drug test.
Inconsistency in Hemp and Marijuana Derived CBD products Could Present Unknown THC Levels:
Cannabis is illegal at a federal level in the United States and therefore has no universal regulations on quality control. A growing concern has developed around purity and consistency within the cannabis industry due to the state by state legalization. Since cannabis is regulated at a state level, there are varying requirements on testing and labeling standards across the nation. Customers run into situations where they begin using a CBD product that works for them only to purchase that same product again with different results. This issue in part is an outcome of companies changing strains of weed for a product when previously used strains aren’t available or farmers changing crops due to infestations or climate. Alongside these changes, some companies don’t retest and then label their products with accurate CBD/THC levels or even ingredients.
In fact, a study was done in 2016 and published on JAMA to examine the accuracy of labels on CBD products found online. The professionals of this study bought 84 online CBD products and removed their labeling for blind testing. What they found was, out of 84 CBD products online, only 30.95% were labelled accurately. For the other 69.05% of the products: 42.85% were underlabelled (they had less CBD than advertised) and 29.18% were overlabelled (they had more CBD than advertised). They also found that 18 of the 84 products (21.43% of the products) contained THC, some with levels high enough to produce psychoactive effects. With inconsistent testing and labeling it can be hard to guarantee that a CBD product derived from hemp or cannabis will not contain THC levels that may cause a failed drug-test.
Moral of the Blog:
All in all, No CBD will not show up on your drug test, but THC might. If you are not careful about where you get your product, or research third-party lab results, then there is no guarantee on what levels of CBD or THC are in any given product.
There are many jobs that require drug-testing, make sure you understand your employers drug policy. If you are concerned about THC in your system, consider using a CBD product that is not derived from marijuana or hemp.
While the market for CBD is through the roof, the legalities of this miracle drug get confusing. CBD derived from hemp and cannabis may be legal at a state level, but it’s still federally illegal. If you are shopping around for a CBD product, there are some legal issues you should know about hemp or cannabis-derived products.
If you’re living in the United States chances are you’ve heard, seen or perhaps even tried CBD and are now a total convert. CBD- short for Cannabidiol- is one of many cannabinoids commonly found in hemp and marijuana that has no psychoactive effect and has been marketed as a cure-all drug in the health and wellness industry due to growing research suggesting it as a remedy for a long list of ailments.
You can find CBD products at dispensaries, grocery stores and even readily available online… which can make its legal status a little confusing. If you can buy CBD online and at the local market, it must be legal right? Well… not exactly and certainly not everywhere.
As of now, the legalities of CBD in the United States are swimming in a grey area of what is considered legal at a federal level and at a state level. Here is an update on where we are with the legalities of CBD in the United States so that you won’t be on the wrong side of the law due to faulty interpretations of federal laws:
CBD Extracted from Cannabis and the Federal Government:
According to the DEA (The Drug Enforcement Administration), CBD derived from cannabis is still considered a Schedule I drug, a class of drugs considered high risk for abuse with no medical purposes. It’s hard to believe that even CBD, a non psychoactive drug remains in this Schedule. The catch is, CBD itself isn’t listed as a Schedule I drug, only cannabis and anything that is connected to the plant. So, CBD can be legal so long as it’s NOT derived from a plant of the genus Cannabis (that includes hemp!).
There has been talk about rescheduling CBD to a Schedule II or III drug, due to the FDA’s (Food and Drug Administration) acceptance of Epidiolex – a cannabis derived pure CBD pharmaceutical drug for epilepsy- to be sold by prescription in pharmacies nationwide. Because of the FDA’s acceptance of Epidiolex, CBD must be rescheduled in order for this drug to legally enter the market.
But until then, at a Federal level, CBD derived from cannabis is still illegal and it is still illegal to sell and ship CBD across state lines. The DEA has admitted that they have bigger concerns than busting people for buying CBD products; but in some states such as Tennessee, retailers are being raided by local police for selling cannabis derived CBD products that they thought were legal.
CBD Extracted from Industrial Hemp and the Federal Government:
According to Leafly, In 2016 the DEA made a ruling that created a new Controlled Substance Act Drug Code for “Marijuana Extracts” which places extracts as a Schedule I drug and Federally illegal. The new CSA defines extracts, “Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus cannabis, other than the separate resin (whether crude or purified) obtained from the plant.” Because industrial hemp’s genus is Cannabis Sativa L, it too falls under this new CSA code and places industrial hemp-derived CBD as illegal by federal law in the United States.
A lot of the confusion surrounding the legalities of CBD derived from industrial hemp comes from the Federal Agricultural Act of 2014, or better known as the Farm Bill. According to the Farm Bill, the cultivation of industrial hemp is legal so long as a state’s Department of Agriculture grows industrial hemp for research or an approved institution under an agricultural pilot program cultivates hemp strictly for educational and research purposes.
Its legal in some states to grow industrial hemp for research, but that doesn’t mean its legal to sell as CBD extracts, although many companies in the industrial hemp industry interpret it that way! And because of that, we see industrial hemp-derived CBD products being falsely marketed as legal in all 50 states. Industrial-hemp based CBD follows the same federal laws as cannabis-based CBD. It is federally illegal and it is illegal to ship across state lines because of its connection as a genus cannabis plant.
InSeptember 2018, Congress may pass legislation in the 2018 Farm Bill that will federally legalize the cultivation of hemp as an agricultural commodity. Senators such as Mitch McConnell and James Comer from Kentucky are on the Farm Bills Congressional committee and will be advocating for the legalization of hemp. This could potential remove hemp-derived CBD from the federal control substance list, but until then hemp-derived CBD is still considered illegal at a federal level.
CBD and the 50 states
Until cannabis is legalized nationally, most CBD products on the market today will remain illegal at a Federal level, but they may be legal depending on your state laws. The legalities of CBD based on state laws are pretty easy to comprehend.
If your state has passed a law allowing medical and recreational use of marijuana, then it is legal for you to use CBD products. If your state only allows medical marijuana, then you need a medical marijuana card to use CBD products unless the product is not derived from cannabis (Like us!). If marijuana is not legalized for medical or recreational purposes in your state, then you can only use CBD that is NOT derived from cannabis (Again, like us!). Regardless of your State's laws around Marijuana, it is illegal to ship, or carry any marijuana or hemp products across state lines! because it’s not federally legal yet.
Here is a list of states and their laws around Medical and Recreational Marijuana:
States with legalized Marijuana for Recreational and Medical use:
Alaska, Washington State, Oregon, California, Nevada, Colorado, Vermont, Massachusetts, Maine and lastly, Washington D.C.
States only with legalized Medical Marijuana:
Hawaii, Arizona, New Mexico, Oklahoma, Arkansas, Louisiana, Florida, Maryland, Delaware, New Jersey, Connecticut, Rhode Island, New Hampshire, New York, Pennsylvania, West Virginia, Ohio, Michigan, Illinois, Minnesota, North Dakota, and Montana.
States that have not yet legalized marijuana for recreational or medical use:
Idaho, Wyoming, Utah, Texas, Kansas, Nebraska, South Dakota, Iowa, Missouri, Wisconsin, Indiana, Kentucky, Tennessee, Mississippi, Alabama, Georgia, South Carolina, North Carolina, and Virginia.
The FDA approved the first-ever CBD drug to be sold in pharmacies nationwide. While this led to the rescheduling of FDA approved CBD drugs in the Controlled Substance Act, it didn’t include CBD in itself, as many advocates had anticipated.
It’s no lie that the legalities around cannabis-based CBD in the U.S. are confusing: You have state laws vs. federal laws that have a combination of contradicting laws that can leave many unsure of what is legal or not. Well, to add to that confusion, the Food and Drug Administration (FDA) announced this past June that they have approved of Epidiolex- a cannabis-based CBD drug used to treat two rare forms of epilepsy- to be distributed by prescription in pharmacies nationwide. This caused a stir of excitement as many in the Cannabis Industry and advocates had anticipated that this would push a rescheduling of CBD entirely.
Currently, all forms of cannabis or hemp derived CBD are considered a Schedule I narcotic: Drugs with high risk for abuse with no known medical purpose. So, in result of the FDA’s acceptance of Epidiolex to be distributed nationally, it became necessary that the Drug Enforcement Agency (DEA) reschedule CBD to a lower level on the Controlled Substance Act (CSA) within 90 days. It is the only way that this drug can be sold legally in the United States. According to Business Insider, the DEA’s public affairs spokesperson, Barbara Carreno, in response to the FDA’s decision stated that, CBD, “absolutely has to become Schedule 2, 3, 4, or 5.” Creating hope for many that Epidiolex may cause cannabis-derived CBD to be rescheduled.
But this past Friday, September 28th the DEA did not reschedule cannabis-derived CBD, they announced that only Epidiolex and other FDA approved cannabis-based drugs will be reclassified as a Schedule V drug- the lowest level on the CSA. This leaves all other cannabis and hemp-derived CBD products on the market today as Schedule I narcotics and federally illegal.
The acceptance of Epidiolex to be prescribed nationally serves as a huge milestone for the U.S. being that it is the first-ever cannabis-based drug to be approved by the FDA. This may open the door for more research around the medicinal uses of CBD and lead other CBD drugs to be approved by the FDA. In their press release, FDA Commissioner Scott Gottlieb, M.D. states, “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And, the FDA is committed to this kind of careful scientific research and drug development.” While the FDA admits that cannabis can have medical purpose, they still have strict policies for cannabis-based drugs such as proof of proper clinical trials and that drugs cannot contain more than .1% THC.
Others are concerned that with the FDA regulating specific CBD drugs, big pharmaceutical companies will take advantage of the market, affecting patient’s access to affordable treatment. Leafly editor Ben Adlin states, “Some in the cannabis community have expressed concern that by narrowly opening the door to only certain CBD pharmaceuticals, patients may actually have a harder time obtaining—and affording—CBD medicine. Epidiolex, for example, is anticipated to cost $32,500 per year, which GW Pharmaceuticals’ CEO has said is roughly in line with other brand-name epilepsy drugs.” While other CBD drugs may become FDA approved, it may affect the already affordable CBD market that exists in states where marijuana has been legalized.
To clear up any confusion, here is what you should take away from all of this: Cannabis-based CBD was not rescheduled, only Epidiolex and other FDA approved drugs (which currently is only Epidiolex). All other cannabis-based (that includes hemp) CBD products are still Schedule I narcotics and federally illegal. So, if a product is hemp or cannabis derived CBD, you have to abide by the state and federal laws regarding cannabis. But there are CBD products available that are not derived from the genus cannabis and are not on the CSA, therefore legal nationwide.